RISE Life Science Corp. announced earnings results for the second quarter ended May 31, 2019. For the second quarter, the company announced net loss was CAD 1.725 million compared to CAD 1.262 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.03 a year ago. For the half year, net loss was CAD 3.546 million compared to CAD 1.760 million a year ago. Basic loss per share from continuing operations was CAD 0.06 compared to CAD 0.04 a year ago.